Search

everythinglearnresearchcommunity

for

Search:↓

The supplement with Serenoa repens and Pygeum africanum significantly increased active hair growth and decreased rest phase hair in post-menopausal women with hair loss, with only mild digestive side effects.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

Selencin effectively reduces hair loss and improves hair health in diffuse alopecia.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

Albizia saponaria bark ethanol extract, particularly at 15%, promotes hair growth in rabbits.

Serenoa repens may help with prostate issues, but more research is needed to confirm its effectiveness.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Researchers developed a new method to find substances in herbs that can block a specific enzyme linked to hair loss.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

Adding baricitinib will increase costs but offers more treatment options for alopecia areata.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

Topical 1% sildenafil is not recommended for treating alopecia areata in children.

Saw palmetto is effective for men's prostate issues, may help women with certain conditions, and could potentially treat hair loss, but should be used carefully due to possible side effects and interactions.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

Combining medications is more effective for treating benign prostatic syndrome symptoms.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.